564 related articles for article (PubMed ID: 28127997)
1. Investigational drug therapies for the treatment of gastroparesis.
Sanger GJ; Pasricha PJ
Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
[TBL] [Abstract][Full Text] [Related]
2. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
Stapleton J; Wo JM
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
[TBL] [Abstract][Full Text] [Related]
3. Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis.
Sanger GJ; Andrews PLR
Aliment Pharmacol Ther; 2023 May; 57(9):962-978. PubMed ID: 36919196
[TBL] [Abstract][Full Text] [Related]
4. New developments in the treatment of gastroparesis and functional dyspepsia.
Tack J; Camilleri M
Curr Opin Pharmacol; 2018 Dec; 43():111-117. PubMed ID: 30245474
[TBL] [Abstract][Full Text] [Related]
5. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
6. Safety of treatment for gastroparesis.
Sarosiek I; Bashashati M; McCallum RW
Expert Opin Drug Saf; 2016 Jul; 15(7):937-45. PubMed ID: 27031006
[TBL] [Abstract][Full Text] [Related]
7. Gastroparesis: separate entity or just a part of dyspepsia?
Stanghellini V; Tack J
Gut; 2014 Dec; 63(12):1972-8. PubMed ID: 25260920
[TBL] [Abstract][Full Text] [Related]
8. The relationship between gastric motility and nausea: gastric prokinetic agents as treatments.
Sanger GJ; Broad J; Andrews PL
Eur J Pharmacol; 2013 Sep; 715(1-3):10-4. PubMed ID: 23831391
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives.
Stevens JE; Jones KL; Rayner CK; Horowitz M
Expert Opin Pharmacother; 2013 Jun; 14(9):1171-86. PubMed ID: 23663133
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.
Sanger GJ; Furness JB
Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):38-48. PubMed ID: 26392067
[TBL] [Abstract][Full Text] [Related]
12. Resolution of severe gastroparesis induced by parasympathetic surge following facial trauma: a case report.
Haseeb-Ul-Rasool M; Elhawary A; Saha U; Sethi A; Swaminathan G; Abosheaishaa H
J Med Case Rep; 2024 May; 18(1):248. PubMed ID: 38750592
[TBL] [Abstract][Full Text] [Related]
13. Gastric electrical stimulation for the treatment of diabetic gastroparesis.
Guerci B; Bourgeois C; Bresler L; Scherrer ML; Böhme P
Diabetes Metab; 2012 Nov; 38(5):393-402. PubMed ID: 22742875
[TBL] [Abstract][Full Text] [Related]
14. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
[TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data.
Wo JM; Ejskjaer N; Hellström PM; Malik RA; Pezzullo JC; Shaughnessy L; Charlton P; Kosutic G; McCallum RW
Aliment Pharmacol Ther; 2011 Mar; 33(6):679-88. PubMed ID: 21214610
[TBL] [Abstract][Full Text] [Related]
16. Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study.
Kendall BJ; Kendall ET; Soykan I; McCallum RW
J Int Med Res; 1997; 25(4):182-9. PubMed ID: 9283990
[TBL] [Abstract][Full Text] [Related]
17. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features.
Pasricha PJ; Grover M; Yates KP; Abell TL; Bernard CE; Koch KL; McCallum RW; Sarosiek I; Kuo B; Bulat R; Chen J; Shulman RJ; Lee L; Tonascia J; Miriel LA; Hamilton F; Farrugia G; Parkman HP;
Gastroenterology; 2021 May; 160(6):2006-2017. PubMed ID: 33548234
[TBL] [Abstract][Full Text] [Related]
18. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder.
Donthireddy KR; Ailawadhi S; Nasser E; Schiff MD; Nwogu CE; Nava HR; Javle MM
J Support Oncol; 2007 Sep; 5(8):355-63. PubMed ID: 17944143
[TBL] [Abstract][Full Text] [Related]
19. Prokinetics in diabetic gastroparesis.
Hejazi RA; McCallum RW; Sarosiek I
Curr Gastroenterol Rep; 2012 Aug; 14(4):297-305. PubMed ID: 22688694
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and pathophysiology of gastroparesis.
Nguyen LA; Snape WJ
Gastroenterol Clin North Am; 2015 Mar; 44(1):21-30. PubMed ID: 25667020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
